Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tabernero

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
European Urology|January 1, 1997
Growing teratoma syndrome: experience of a single institutionP Maroto, J M Tabernero, H Villavicencio, et al.
Bone Marrow Transplantation|February 26, 1999
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantationR Salazar, C Solá, P Maroto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the adjuvant treatment of colorectal cancerCristina Grávalos Castro, Joan Maurel Santasusana, Fernando Rivera Herrero, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose ChemotherapyC. Solá, P. Maroto, R. Salazar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) studyE Aranda, E Díaz-Rubio, A Cervantes, et al.
Clinical Colorectal Cancer|August 16, 2005
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II studyChris J Twelves, Charles A Butts, Jim Cassidy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up resultsBernhard K Krämer, Giuseppe Montagnino, Domingo Del Castillo, et al.
The Oncologist|May 31, 2012
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, M Luisa Maestro, Auxiliadora Gómez-España, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2008
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational resultsBernhard K Krämer, Domingo Del Castillo, Raimund Margreiter, et al.
British Journal of Cancer|April 12, 2012
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumoursT A Yap, H Cortes-Funes, H Shaw, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
European Urology|January 1, 1997
Growing teratoma syndrome: experience of a single institutionP Maroto, J M Tabernero, H Villavicencio, et al.
Bone Marrow Transplantation|February 26, 1999
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantationR Salazar, C Solá, P Maroto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the adjuvant treatment of colorectal cancerCristina Grávalos Castro, Joan Maurel Santasusana, Fernando Rivera Herrero, et al.
Hematology (Amsterdam, Netherlands)|June 16, 2001
Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose ChemotherapyC. Solá, P. Maroto, R. Salazar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) studyE Aranda, E Díaz-Rubio, A Cervantes, et al.
Clinical Colorectal Cancer|August 16, 2005
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II studyChris J Twelves, Charles A Butts, Jim Cassidy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up resultsBernhard K Krämer, Giuseppe Montagnino, Domingo Del Castillo, et al.
The Oncologist|May 31, 2012
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors studyJavier Sastre, M Luisa Maestro, Auxiliadora Gómez-España, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2008
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational resultsBernhard K Krämer, Domingo Del Castillo, Raimund Margreiter, et al.
British Journal of Cancer|April 12, 2012
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumoursT A Yap, H Cortes-Funes, H Shaw, et al.
Pageof 9